Cell Death Discovery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-24 123dc049m24(暂无昵称) 来自广东省

从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了

23 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-04-24 白衣13 来自伊利诺伊

求好运，编辑和审稿人一生平安！！！

Manuscript Under Consideration 11th Apr 24 05:59:46
Editor Assigned 10th Apr 24 04:50:35
Manuscript Received 10th Apr 24 04:50:34

28 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-25 36192448 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊

17 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2022-01-10 Pig1000

请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received

43 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-27 ms9000000424678117 来自山东省

请问要求未剪裁整膜，可以目的和内参不在一张膜吗

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-24 123dc049m24(暂无昵称) 来自广东省

从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-20 ms6000001702952186 来自河南省

偏重的研究方向：肿瘤转移;肿瘤生物学
经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-05-09 ms4000000471597518 来自重庆

请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2024-06-05 ms3000000526945160 来自湖北省

偏重的研究方向：机制
经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1182903, encodeId=2b621182903a8, content=请问各位，原则性接收上传最终稿后，走的流程还会不会有under consideration，现在上传已经4天了，还是manuscript received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6535602345, createdName=Pig1000, createdTime=Mon Jan 10 18:12:03 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2211975, encodeId=1b8322119e522, content=请问要求未剪裁整膜，可以目的和内参不在一张膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85f09193690, createdName=ms9000000424678117, createdTime=Thu Jun 27 19:13:21 CST 2024, time=2024-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210907, encodeId=af9f221090ee3, content=偏重的研究方向：肿瘤转移;肿瘤生物学 经验分享：哈哈哈哈！以前投的Q2，今天升Q1了哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Thu Jun 20 23:09:49 CST 2024, time=2024-06-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2203732, encodeId=e3e72203e32b5, content=请问修改后的版本要怎么上传呢，我看邮件链接里没有可以上传修订后版本的地方, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe18212751, createdName=ms4000000471597518, createdTime=Thu May 09 20:49:01 CST 2024, time=2024-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2208362, encodeId=4d612208362d2, content=偏重的研究方向：机制 经验分享：大家一般投稿后多久才送审啊？我的已经投了7天了，还在编辑那里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Wed Jun 05 06:09:13 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167353, encodeId=b340216e35352, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经系统凋亡及机制 经验分享：更新一下投稿时间线： Manuscript Received： 7.3 Editor Assigned ：7.3 Manuscript Under Consideration： 7.4 Manuscript Under Consideration： 8.31 Decision Made： 9.2 Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回） Manuscript Received： 10.18 Editor Assigned： 10.18 Manuscript Under Consideration： 10.19 目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=59, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daea8237862, createdName=ms6000000748440029, createdTime=Wed Nov 08 10:04:15 CST 2023, time=2023-11-08, status=1, ipAttribution=广东省)]

2023-11-08 ms6000000748440029 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：神经系统凋亡及机制
经验分享：更新一下投稿时间线：
Manuscript Received： 7.3
Editor Assigned ：7.3
Manuscript Under Consideration： 7.4
Manuscript Under Consideration： 8.31
Decision Made： 9.2
Decision Sent to Author： 9.8 （一审65天，等的急啊；要求11.1前返回）
Manuscript Received： 10.18
Editor Assigned： 10.18
Manuscript Under Consideration： 10.19
目前返回20天了，research square状态还是 Submission checks complete，编辑还没有返回审稿人手里，要怎么办呀？要催吗？二审一般多久呀？

53 59

展开59条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务